Compiling observations and administration of Golden Sunrise Nutraceutical (Golden Sunrise) dietary supplement products should always be under the supervision of a licensed physicians, registered nurse, and medical specialists in the medical field. Recommendations for Golden Sunrise products are based on the following criteria; Medical evaluation, assessment, diagnosis, monitoring, and medical report results of the patient.
1.0. CANCER CASE REPORTS
1.1. Patient with Pancreatic Cancer.
G.T. is a 71-year-old Hispanic male that was diagnosed with stage four pancreatic cancer on May 01, 2025. Patient complained of lower back pain, was increasingly constipated, fatigued, and depressed from the diagnosis. Patient heard of Golden Sunrise products for alternative Cancer Treatment through his family and set up an appointment with Oakview Medical Group. Patient agreed to try it's Cancer Treatment and Sonja I. FONTANA (Mrs. Fontana) discussed his options and prescribed Cancer Treatment for him on May 17, 2025. Results: Shortly after patient was taking Cancer Treatment, he could have a Bowel Movement (BM) and after this he steadily improved his BM to 3-times per day. After a month patient's energy level noticeably improved, patient's health improved where he could walk outside, his depression no longer was an issue, his back pain which he claimed he suffered from for many years no longer was an issue, recovery continued and his health improved, mental clarity, and none of the previous issues were of note by this time.
AFTER CANCER TREATMENT FINDINGS: On July 21, 2025 MR Abdomen W/WO Contrast, MRI, and CT. Pancreatic head mass as following:
Date Pancreatic Ductal Dilation Heterogeneous Bones
Before Cancer Treatment: May 01, 2025 8-mm 2.7 x 2.6-cm Mild Degenerative Endplate Narrow Changes
After Cancer Treatment: July 21, 2025 5-mm 2.5 x 1.4-cm No Significant Abnormality
AFTER CANCER TREATMENT FINDINGS: On May 09, 2025 and July 21, 2025 Blood Report Results as following:
Date Alkaline Phosphatase Bilirubin AST (SGOT) ALT (SGPT) Creatinine
Before Cancer Treatment: April 30, 2025 1050-IU/L 4.7-mg/dL 159-IU/L 155-IU/L 0.75-mg/dL
After Cancer Treatment: May 09, 2025 475-IU/L 1.3-mg/dL 47-IU/L 58-IU/L 0.56-mg/dL
July 21, 2025 96-IU/L 0.3-mg/dL 30-IU/L 25-IU/L 1.30-mg/dL
CONCLUSION: (1) Poorly defined mass at pancreatic head is difficult to delineate due to motion artifacts as described above, grossly stable. The tumor is again abutting the SMV for 180 degrees. No definite involvement of the SMA or portal vein definitively. (2) Mildly improved pancreatic ductal dilatation in the body and tail and mildly improved intrahepatic bile duct dilatation in the left lobe, with suggestion of bile duct stent in place. (3) Porta hepatis and peripancreatic lymphadenopathy. (4) Bilateral lung base patchy nodular hyperintense signals, not well assessed with MRI. Correlation with chest CT.
On July 21, 2025 MR Pelvis Male W/O Contrast. Pancreatic head as following:
CONCLUSION: (1) Bilateral inguinal lymph nodes, measuring up to 1-cm in short axis. These are nonspecific and may be reactive. (2) Bilateral obturator and external iliac chain lymph nodes, measuring up to 0.9-cm in short axis on the right. These are nonspecific and may be reactive. (3) No definitive metastatic disease in the pelvis.
1.2. Patient with Prostate Cancer.
C.S. is an 83-year-old white male that was diagnosed with prostate cancer on October 10, 2024. Patient complained of an increase feeling tired all the time and had no energy function in day-to-day task. After patient diagnosis he was asked to take chemotherapy treatment by his initial physician but refused. Patient was looking for alternative therapies and wished to used herbal, botanical, or nutritional alternatives. Patient heard Golden Sunrise dietary supplement products for alternative Cancer Treatment and consented to take alternative Cancer Treatment. The Cancer Treatment was administered by Oakview Medical Group under supervision of Mrs. Fontana. Results: After Cancer Treatment, patient again said he had more energy to do whatever he wanted and was very happy with the results from alternative Cancer Treatment. Patient went to his oncologist for medical checkup as his prostate cancer on May 10, 2025. The oncologist and received blood report results that showed patient improvement and did not move forward with any chemotherapy treatment and said to keep doing what you are doing.
AFTER CANCER TREATMENT FINDINGS: On September 08, 2025 Compute Tomography (CT) scan Abd and Pelvis W and W/O Contrast as following:
Date Prostate Specific Antigen (PSA)
Before Cancer Treatment: October 10, 2024 13-ng/mL
After Cancer Treatment: November 05, 2024 9.6-ng/mL
IMPRESSION: Stable exam without convincing evidence for tumor recurrence on this study. Begin-appearing stable right kidney cysts.
2.0. DIABETES CASE REPORT
2.1. Patient with Type 1 Diabetes.
N.O. is a 20-year-old white male that was diagnosed with Type 1 Diabetes on February; 2011. Patient requires lifelong insulin injections daily to manage his blood glucose levels. Patient's diet is restrictive though the patient rarely follows his diet regiment. Patient started with Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on May 10, 2019. Results: After the patient was administered the Metabolic Treatment, the patient was then monitored by medical staff for a response. After a short period of time the patient's blood glucose levels showed a significant decrease from 440-mg/dL to 60-mg/dL in less than two hours without the patient experiencing any symptoms such as dizziness, weakness, sweating, the patient did not demonstrate any adverse-effects, etc., and still carry on the usual daily activities.
AFTER METABOLIC TREATMENT FINDINGS: Blood sugar level as following:
Time Blood Sugar Level
Before Metabolic Treatment: 11:00 A.M. 440-mg/dL
After Metabolic Treatment: 1:00 P.M. 60-mg/dL
3.0. MENOPAUSE CASE REPORT
3.1. Patient with Menopause.
S.T. is a 59-year-old white female that was diagnosed with Osteoporosis, Migraine Headaches, and Gastroesophageal Reflux Disease (GERD) in May; 2013. Osteoporosis has been showing a steady degradation of bone density since its diagnoses which has increased other symptoms. The patient is complaining of increased neck and back pain to the point of possible future immobility. Patient started with Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on July 18, 2017. Results: After the Metabolic Treatment has overall dramatic results for pain that does not seem to have any real cause. It also has an effect on patient nails and skin. These changes were fairly quick. Taking more time is the slight to moderate improvement in thumb arthritis, GERD symptoms, neck migraines, and migraines, foot pain. Hip pain is reduced but patient most significant pain remaining. Patient have a relatively steady more energy supply and do not feel hunger as much. Sleep has been difficult, the first three-weeks patient didn’t sleep enough, but felt fairly good. The last week patient have been sleeping more, but don’t feel rested.
AFTER METABOLIC TREATMENT FINDINGS: On June 26, 2018 Dual Femur Bone Density testing uses Dual-Energy X-Ray Absorptiometry (DEXA) scans as following:
Densitometry Trend: Total Mean
Date Age (Years) Bone Mineral Density (BMD) Change vs Previous Change vs Baseline
Before Metabolic Treatment: July 05, 2017 58.5 0.780-g/cm2 --2.7% --6.3%
After Metabolic Treatment: June 26, 2018 59.5 0.808-g/cm2 3.6% --2.9%
Densitometry Trend: L1-L4
Date Age (Years) Bone Mineral Density (BMD) Change vs Previous Change vs Baseline
Before Metabolic Treatment: July 05, 2017 58.5 0.857-g/cm2 --3.6% --6.2%
After Metabolic Treatment: June 26, 2018 59.5 0.886-g/cm2 3.4% --3.1%
IMPRESSION: (1) Osteoporosis.
(2) Lumbar spine bone density is not significantly changed from prior studies. Hip bone density is significantly increased from Year-2017.
4.0. COVID-19 CASE REPORTS
4.1. Patient with COVID-19.
S.R. is a 87-year-old Hispanic male that was diagnosed positive with COVID-19 on April 14, 2020. Patient has diabetes mellitus type II, hypertension, heart attack history with by-pass graft surgery, but no history of lung or kidney problems. Patient was recovering from right hip surgery at a nursing home when he was sent to Hospital Center (Hospital) in VISALIA California, for respiratory distress on April 14, 2020. Patient chest X-ray showed bilateral pneumonia and he tested positive for COVID-19 that day. Patient required intubation tube and ventilator support in the Intensive Care Unit (ICU) on April 14, 2020. On the day before patient was discharged on April 28, 2020, when he was on a regular Hospital floor, the doctor was willing to start the Golden Sunrise Nutraceutical products as part of the Metabolic Treatment (Metabolic Treatment) at the family’s request. Results: After Metabolic Treatment, patient was discharged from the Hospital on April 29, 2020 without repeat COVID-19 testing since he was going home. When patient was discharged from the Hospital, he did not display any the typical symptoms of COVID-19 illness, such as cough, Shortness of Breath (SOB), chest tightness, muscle aches/pains, or fevers. Patient was not requiring any oxygen, but he was extremely weak, and he was eating poorly.
AFTER METABOLIC TREATMENT FINDINGS: Patient was discharged from the Hospital as following:
Date Hospital Treatment
Before Metabolic Treatment: April 28, 2020 Intubation Tube (Ventilation)
After Metabolic Treatment: April 29, 2020 Discharged from Hospital
4.2. Patient with COVID-19.
M.T. is a 50-year-old white female that was diagnosed positive with COVID-19 on April 05, 2020. Patient is a Registered Nurse (RN) who was in direct care with elderly patient, she obtained a COVID-19 swab test on April 03, 2020, and she tested positive for COVID-19 at Convalescent Center in VISALIA California on April 05, 2020. Patient started self-quarantine because of onset of a mild sore throat, bad headache, a one time fever of ninety-nine point six (99.6°F) degrees Fahrenheit, generalized muscle achiness, nasal congestion, and fatigue. Patient had mild dry cough and perhaps tightness with breathing (although she has had this type of breathing sensation in the past with allergies). Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic treatment) on April 04, 2020. Results: Patient has felt some improvement through April 06, 2020 with the muscle aches, pains, headache, nasal congestion, fatigue, and much improved cough. Patient completed the Metabolic Treatment and she became asymptomatic. On April 05, 2020 through May 27, 2020 COVID-19 tested from DETECTED to NOT DETECTED.
AFTER METABOLIC TREATMENT FINDINGS: On May 27, 2020 COVID-19 Polymerase Chain Reaction test results as following:
Date COVID-19 Polymerase Chain Reaction (PCR) Reference Range
Before Metabolic Treatment: April 05, 2020 Detected (Positive)
After Metabolic Treatment: May 27, 2020 Not Detected (Negative)
4.3. Patient with COVID-19.
R.H is a 51-year-old Hispanic male that was diagnosed positive tested with COVID-19 on April 02, 2020. Doctor referred patient to Golden Sunrise Nutraceutical for COVID-19 treatment on April 08, 2020 after he failed a five days course of Hydroxychloroquine and Azithromycin. Patient symptoms started a few days before, on March 30, 2020 and they had not improved any on that combination of prescription drugs per the patient. Patient symptoms are the same; fever every day (the highest one hundred and three point five (103.5°F) degrees Fahrenheit), chills, extreme fatigue, severe generalized muscle achiness and pain, severe headaches, tightness in his chest with breathing and frequent dry coughing, throat irritation, insomnia, poor appetite with several pond weight loss, ongoing diarrhea, and no nasal congestion. Patient sense of smell and taste have not been affected. Patient has had Diabetes Mellitus type II for some fifteen (15) years and is on insulin. Patient has diabetic peripheral neuropathy, chronic tinnitus, and balance problems from the diabetes. Patient suffers from Asthma and using Symbicort inhaler twice a day as usual. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on April 08, 2020. Results: The day after patient started Metabolic Treatment on April 08, 2020. On April 13, 2020 patient fever started to drop and he remained a febrile by day number six of treatment. Essentially asymptomatic after Metabolic Treatment taken on day number eight on April 15, 2020, except for some persisting chest tightness/cough. Asymptomatic for five days and COVID-19-Positive on April 17, 2020 and on April 18, 2020 patient jogged for two miles. Patient never had any more worsening of cough or chest tightness other than what was consistent with baseline asthma symptoms per patient. Brief conversation asymptomatic, feeling very good, no fevers, and only slight chest tightness consistent with his asthma. On April 02, 2020 through April 25, 2020 COVID-19 tested from DETECTED to NOT DETECTED.
AFTER METABOLIC TREATMENT FINDINGS: On April 25, 2020 and COVID-19 Polymerase Chain Reaction test results as following:
Date COVID-19 Polymerase Chain Reaction (PCR) Reference Range
Before Metabolic Treatment: April 02, 2020 Detected (Positive)
After Metabolic Treatment: April 25, 2020 Not Detected (Negative)
4.4. Patient with COVID-19.
N.M. is a 63-year-old white female that was diagnosed positive with COVID-19 on April 03, 2020. Patient started her COVID-19 illness about March 19, 2020 with persistent symptoms for three weeks. Patient failed Ciprofloxacin medicine trial and was COVID-19 tested positive on April 03, 2020. On April 08, 2020 patient stopped after only one dose of Hydroxychloroquine and Azithromycin. Patient does have hypertension (Verapamill). Patient has been symptomatic since March 20, 2020 after her vacation in the NETHERLANDS Holland. Her husband became sick first, because of his slow improvement, she was to start the Hydroxychloroquine, and Azithromycin. Doctor referred patient to Golden Sunrise Nutraceutical for COVID-19 treatment on April 08, 2020, after patient failed a five days course of Hydroxychloroquine and Azithromycin. Patient symptoms were low grade fevers in the range of about ninety-nine point four to ninety-nine point nine (99.4°F – 99.9°F) degrees Fahrenheit in the two weeks, no chills, but she was in bed for a few days with headaches, generalized achiness, severe dry cough, and Shortness of Breath (SOB). Patient failed a course of Ciprofloxacin by her primary care physician. Patient persisting symptoms are some chest tightness, SOB, nagging dry cough (although some productiveness this last week), and poor energy. Appetite is almost normal, but she only wants soups, and ‘soft food’. Doctor referred patient to Golden Sunrise Nutraceutical for COVID-19 treatment on April 08, 2020. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on April 08, 2020. Results: After six days of Metabolic Treatment patient became asymptomatic from her lower energy, cough, low fevers, etc. on day numer of treatment. Patient has not required any further treatment, such as with the Metabolic Treatment, having been asymptomatic since day number seven. On April 27, 2020 patient feeling one hundred percent better, and she feels completely normal. On April 04, 2020 through April 30, 2020 COVID-19 tested from POSITIVE to INCONCLUSIVE.
AFTER METABOLIC TREATMENT FINDINGS: On April 30, 2020 and COVID-19 Polymerase Chain Reaction test results as following:
Date COVID-19 Polymerase Chain Reaction (PCR) Reference Range
Before Metabolic Treatment: April 04, 2020 Detected (Positive)
After Metabolic Treatment: April 30, 2020 Inconclusive
4.5. Patient with COVID-19.
D.M. is a 65-year-old white male that was diagnosed positive with COVID-19 on April 09, 2020. Patient became symptomatic after returning from the NETHERLANDS Holland, on March 17, 2020 persisting symptoms for three weeks, patient began feeling fever, chills for few days, stayed in bed, patient was also experiencing mild headaches, generalized muscle aches and pain, some nasal burning sensation, a bad dry cough, wheezing, tightness in his chest, primarily with deep breathing with resultant coughing, low energy, poor smell, and taste. Patient stamina is just not the same and he becomes winded and light-headed if works much outside. Doctor referred patient to Golden Sunrise Nutraceutical for COVID-19 treatment on April 09, 2020. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) on April 09, 2020. Results: After the Metabolic Treatment April 09, 2020. On April 15, 2020 asymptomatic by day number seven of treatment and on April 29, 2020 feel totally normal, no more feeling of anything in his chest, no symptoms, and feeling good. On April 09, 2020 through April 28, 2020 COVID-19 tested from POSITIVE to NOT DETECTED.
AFTER METABOLIC TREATMENT FINDINGS: On April 28, 2020 and COVID-19 Polymerase Chain Reaction test results as following:
Date COVID-19 Polymerase Chain Reaction (PCR) Reference Range
Before Metabolic Treatment: April 09, 2020 Detected (Positive)
After Metabolic Treatment: April 28, 2020 Not Detected (Negative)
5.0. BLOOD LOSS FROM SURGERY CASE REPORTS
5.1. Patient with Surgery Abnormal Uterine Bleeding and Chronic Pelvic Pain.
L.C. is a 55-year-old white female that was diagnosed with abnormal uterine bleeding and chronic pelvic pain on March; 1993. On October 31; 2022 patient was preoperative diagnoses; abnormal uterine fibroids, bilk symptoms, low-grade squamous intraepihelial lesion, history of cesarean delivery, and history laparotomy, history of subtotal coletectomy. Outside imagine revealed an enlarged uterine with multiple uterine fibroids. Management options to proceed with hysterectomy. Ovarian preservation versus oophorectomy was reviewed with the patient including risks, benefits, and alternatives. After verbalizing understanding, the patient desired oophorectomy. Patient started taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) to help with blood loss from surgery on October 19, 2022. Results: As a results of taking Metabolic Treatment, the surgeons and other medical professionals team were very impressed at the minimizing blood loss during operations due to the benefits for patient and the significant improvements in surgical outcomes. Blood loss from surgery estimated blood loss of less than <25-mL. Family patient they were in belief at how well patient was doing without any narcotic pain medication.
AFTER METABOLIC TREATMENT FINDINGS: On October 31, 2020 Blood Loss results as following:
Date Blood Loss Results Classified
Normal Blood Loss During Surgery: Significant Loss 500-mL Considered Significant
After Metabolic Treatment: October 31, 2020 Less Than <25-mL Minimal Bleeding
5.2. Patient with Chronic Surgery Pain.
S.S. is a 80-year-old white female that diagnosed with chronic back pain on May; 2024. Patient tarted taking Golden Sunrise Nutraceutical Metabolic Treatment (Metabolic Treatment) to help with blood loss from surgery. Results: As a results of taking Metabolic Treatment, blood loss from surgery estimated blood loss of less than <150-mL. On September 10, 2025 the surgeons and other medical professionals team were very impressed at the minimizing blood loss during operations due to the benefits for patient and the significant improvements in surgical outcomes.
AFTER METABOLIC TREATMENT FINDINGS: On August 28, 2025 Blood Loss results as following:
Date Blood Loss Results Classified
Normal Blood Loss During Surgery: Significant Loss 500-mL Considered Significant
After Metabolic Treatment: August 28, 2025 Less Than <150-mL Minimal Bleeding
REFERENCES
[1] Tiêu Equation Experimentation of Understanding by Energy Transfer Quantum Mechanics https://www.scirp.org/journal/paperinformation?paperid=123783
[2] Particle Becomes Energy = Energy Becomes Mass https://globaljournals.org/GJSFR_Volume23/E-Journal_GJSFR_(A)_Vol_23_Issue_4.pdf
[3] Life Is Quantum Biology Effects Explained from the Schrödinger Equation, Serious or Life-Threatening Conditions or Diseases, and COVID-19 Results https://www.scirp.org/journal/paperinformation?paperid=120506
[4] Patient Quality-of-Life, Providers with Incentive Payments, Real-World Evidence, and Reducing Healthcare Costs through New Innovations https://www.scirp.org/journal/paperinformation?paperid=124390
[5] The Nobel Prize - Otto Heinrich Warburg https://www.nobelprize.org/prizes/medicine/1931/warburg/biographical/
[6] Wikipedia - Otto Heinrich Warburg https://en.wikipedia.org/wiki/Otto_Heinrich_Warburg
[7] Huu S. TIEU’s Predicting Outcome of Severe Acute Respiratory Syndrome (SARS) and Preparing the Treatment for COVID-19 (Coronavirus) and Other Viral Pandemics https://www.scirp.org/journal/paperinformation?paperid=123247
[8] Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Signed the 21st Century CURES Act into FDA Regulation and Law https://www.scirp.org/journal/paperinformation?paperid=122400
[9] COVD-19 Patient Says Herbal Treatment Helping Her: RN says Golden Sunrise Pharmaceutical has her feeling better https://www.recorderonline.com/news/covid-19-patient-says-herbal-treatment-helping-her-rn-says-golden-sunrise-pharmaceutical-has-her/article_cb85970a-7a74-11ea-9ce6-5f289eb63863.html
[10] Two more COVID-19 patients say treatment has helped them: They were treated with combination of supplements https://www.recorderonline.com/news/two-more-covid-19-patients-say-treatment-has-helped-them-they-were-treated-with-combination/article_d53fbb22-96c1-11ea-a1a0-338151b58d0a.html
Copyright © 2026 Tieu Equation - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.